COMMUNIQUÉS West-GlobeNewswire
 
      -   
  CVRx announces new CPT® Category I codes for Barostim18/10/2024
-   
  HeartFlow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease18/10/2024
-   
  RAMSAY SANTE :Annual results at the end of June 202418/10/2024
-   
  RAMSAY SANTE : Résultats annuels au 30 juin 202418/10/2024
-   
  Advanced Care Group Expands Nationwide with Acquisition of 3D Medical Staffing and AI-Powered Recruiting Solutions18/10/2024
-   
  ClinicPlast: Türkiye ranks in the top ten countries hosting patients from across the globe18/10/2024
-   
  Universal Health Care, LLC Opening a New Path in Healthcare18/10/2024
-   
  Significant Positive Results from Osteoarthritis Clinical Study in Dogs Treated with Piclidenoson18/10/2024
-   
  Jean Health Announces Expansion into Australia: Solving Urgent Rural Maternity Care Needs18/10/2024
-   
  Oragenics, Inc. to Present at The Centurion One Capital 2nd Annual Bahamas Summit18/10/2024
-   
  FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases18/10/2024
-   
  SeaStar Medical Announces that Enrollment in its Adult Acute Kidney Injury Pivotal Trial Has Exceeded the Halfway Point Toward an Interim Analysis18/10/2024
-   
  Vivos Inc. Certifies New Clinic for IsoPet® Precision Radionuclide TherapyTM18/10/2024
-   
  Arcutis Announces Health Canada Approval of ZORYVE® (Roflumilast) Foam 0.3% to Treat Seborrheic Dermatitis in Individuals 9 Years of Age and Older18/10/2024
-   
  Madrigal Pharmaceuticals to Release Third-Quarter 2024 Financial Results and Host Webcast on October 31, 202418/10/2024
-   
  Alignment Healthcare to Announce Third Quarter 2024 Financial Results and Host Conference Call Tuesday, Oct. 29, 202418/10/2024
-   
  Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference18/10/2024
-   
  UPDATE -- Better Choice Company Chairman Issues Letter to Shareholders as Company Continues to Make Progress Towards the Closing of its SRx Health Acquisition18/10/2024
-   
  Phase III trial results of novel triple combination pill for hypertension published in The Lancet18/10/2024
Pages